Zoetis teamed up with AVMA (American Veterinary Medical Association) to share valuable tips and takeaways for pet owners in caring for their pets during coronavirus.
At Zoetis, we know the human-animal bond is powerful. We’ve supported studies to show the benefits of therapy dogs for oncology patients and raised awareness about the ways pets can make people healthier. Now our colleagues in Spain are building on this work by sponsoring therapy dogs for children with autism, to help them develop social skills for the future. Read on to learn more about how these dogs, with the help of Zoetis, are making a difference in children’s lives.
Zoetis recently announced the expansion of its K-9 Courage™ Program to support two American Humane initiatives benefiting military dogs and service dogs that assist veterans: the Wags4Patriots program that helps provide service dogs for veterans who suffer from Post-Traumatic Stress (PTS), and the Emergency Veterinary Grants for Military Dogs program that awards financial grants to provide emergency treatment to retired military dogs in need.
Zoetis-Sponsored Study Shows Therapy Dogs Help Families Cope with Childhood Cancer
Zoetis and veterinary practices across the United Kingdom are calling on dog owners to help raise vital funds to purchase a new assistance dog for the nonprofit organization Hounds for Heroes
Zoetis raised £20,000 for the nonprofit organization Hounds for Heroes with its ‘Pounds for Hounds’ fundraising campaign.
At Zoetis, we understand the special bond shared between people and their pets – and the importance of keeping our canine companions happy and healthy. Today we will focus on how we care for dogs from a dermatology perspective, just one of the many core areas of focus for Zoetis.
Zoetis recently launched its first-ever national, direct-to-consumer television advertising campaigns in the U.S. since becoming an independent company. Two brand-new Zoetis ads started airing on TVs across the U.S. this week, one featuring the company’s canine allergic itch tablet, Apoquel®, and the other starring Simparica®, a once-monthly chewable parasiticide that helps protect dogs from fleas and ticks.
Zoetis recently won two awards for industry-leading innovation in the 2016 Animal Pharm Awards competition. Animal Pharm, the most widely read newsletter reporting on the animal health industry, announced the award winners on January 17.
On September 28, more than 1,250 dog owners and their pets gathered in Rosario, Argentina for the ever-popular DOGRUN, a street race where participants may run or walk with their dogs.
Zoetis recently sponsored the DOGRUN event in Argentina, which aimed to raise awareness among dog owners about the importance of regular veterinary care for their pets.
Through the support of Zoetis, the Smithsonian Institution Traveling Exhibition Service, the American Veterinary Medical Association (AVMA) and the American Veterinary Medical Foundation (AVMF)
Whether it is sending a client a text appointment reminder, ordering medications online using the Zoetis e-Commerce portal or sharing news of interest with clients on Facebook...
In January, Zoetis launched the first and only Janus Kinase (JAK) inhibitor for veterinary use in the United States and Europe.
On May 8, Zoetis joined the American Humane Association (AHA), researchers, families, and country-music star Naomi Judd for a special briefing before Congress.
The connection between humans and animals is powerful. The human-animal bond can be made even more powerful with the help of veterinarians.
Zoetis recently responded to a dog rescue effort in Howell, New Jersey, where nearly 300 dogs were in need of veterinary care and forever homes.
The Zoetis for Shelters program provides exceptional discounts on many of the Zoetis products that shelters use most. The average shelter saves $4,592 a year. This money saved can instead go towards helping more pets find forever homes.
Karen Stasiak, Area Veterinarian for Zoetis, volunteers each year for the annual Can-AM Crown Sled Dog Race.
The U.S. Food and Drug Administration (FDA) has approved Simparica™, a once-monthly chewable flea and tick medication for dogs.
Zoetis recognizes that heroes come in many shapes and sizes – sometimes even on four legs.
First targeted antibody therapy approved for control of clinical signs of atopic dermatitis in dogs
Zoetis has joined an exciting new initiative working to advance the standards of small animal veterinary care across Africa.
Following four years of extreme drought conditions, California's vulnerability to wildfires fires has drastically increased. In mid-September, the Valley fires of Northern California destroyed an...
At our heart, Zoetis is about caring for animals – and some animals need a little more care than others. Adopting an animal from a shelter has many advantages.
Launches First Educational Initiative and Lays Groundwork for the Creation of New Veterinary Associations in Sub-Saharan Africa